ES2191673T3 - Reactivos de diagnostico para la deteccion de anticuerpos contra el virus de epstein barr. - Google Patents

Reactivos de diagnostico para la deteccion de anticuerpos contra el virus de epstein barr.

Info

Publication number
ES2191673T3
ES2191673T3 ES94202598T ES94202598T ES2191673T3 ES 2191673 T3 ES2191673 T3 ES 2191673T3 ES 94202598 T ES94202598 T ES 94202598T ES 94202598 T ES94202598 T ES 94202598T ES 2191673 T3 ES2191673 T3 ES 2191673T3
Authority
ES
Spain
Prior art keywords
protein
epstein barr
detection
diagnostic reagents
vca
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94202598T
Other languages
English (en)
Inventor
Jaap Michiel Middeldorp
Grunsven Wouterus Marinus Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux BV
Original Assignee
Biomerieux BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux BV filed Critical Biomerieux BV
Application granted granted Critical
Publication of ES2191673T3 publication Critical patent/ES2191673T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION ESTA DIRIGIDA A REACTIVOS DE DIAGNOSTICO PARA LA DETECCION DE ANTICUERPOS CONTRA EL VIRUS EPSTEIN BARR Y A UN METODO PARA LA DETECCION DE ANTICUERPOS CONTRA EL VIRUS EPSTEIN BARR EN UNA MUESTRA. LOS REACTIVOS DE DIAGNOSTICO DE ACUERDO CON LA INVENCION COMPRENDEN UNA COMBINACION DE POR LO MENOS PARTE DE UNA PROTEINA ESTRUCTURAL VIRAL EPSTEIN BARR, PREFERIBLEMENTE UNA PROTEINA VCA EPSTEIN BARR O UNA PROTEINA MA EPSTEIN BARR Y POR LO MENOS PARTE DE UNA PROTEINA EBNA EPSTEIN BARR. PREFERIBLEMENTE, LA PROTEINA VCA ES PROTEINA P18-VCA, LA PROTEINA MA ES PROTEINA MA-GP350/220 Y LA PROTEINA EBNA ES PROTEINA EBNA-1. HA SIDO ENCONTRADO QUE LA COMBINACION DE UNA PROTEINA VCA O DE UNA PROTEINA MA Y UNA PROTEINA EBNA EN UNA MUESTRA DE DIAGNOSTICO INDIVIDUAL, PRODUCE UN METODO DE DETECCION DE ANTICUERPOS EBV CON MAYOR SENSIBILIDAD Y PRECISION QUE LOS METODOS CORRIENTES.
ES94202598T 1993-09-14 1994-09-09 Reactivos de diagnostico para la deteccion de anticuerpos contra el virus de epstein barr. Expired - Lifetime ES2191673T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93202659 1993-09-14

Publications (1)

Publication Number Publication Date
ES2191673T3 true ES2191673T3 (es) 2003-09-16

Family

ID=8214091

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94202598T Expired - Lifetime ES2191673T3 (es) 1993-09-14 1994-09-09 Reactivos de diagnostico para la deteccion de anticuerpos contra el virus de epstein barr.

Country Status (13)

Country Link
US (1) US5827646A (es)
EP (1) EP0649904B1 (es)
JP (1) JP3547493B2 (es)
KR (1) KR100378942B1 (es)
AT (1) ATE231556T1 (es)
AU (1) AU679545B2 (es)
CA (1) CA2131874C (es)
DE (1) DE69432043T2 (es)
DK (1) DK0649904T3 (es)
ES (1) ES2191673T3 (es)
FI (1) FI113298B (es)
HK (1) HK1001222A1 (es)
ZA (1) ZA947061B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2765688B1 (fr) 1997-07-04 1999-09-10 Pasteur Institut Reactif de detection et de suivi des infections provoquees par le virus d'epstein-barr et ses applications
DE10307517A1 (de) * 2003-02-21 2004-09-02 Mikrogen Molekularbiologische Entwicklungs-Gmbh Von Kapsidantigenen des Epstein-Barr-Virus abgeleitete Peptide und ihre Verwendung
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
WO2007010623A1 (ja) * 2005-07-22 2007-01-25 Phg Corporation 新規なポリペプチド及びその製造方法
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
US7628150B2 (en) * 2007-08-17 2009-12-08 Vladimir Malkov Versatile flexible mat and method of implementing and using same
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
KR101678553B1 (ko) 2012-04-30 2016-11-22 (주)바이오니아 엡스타인-바 바이러스 검출용 키트 및 이를 이용한 엡스타인-바 바이러스의 검출방법
WO2014025254A1 (en) 2012-08-10 2014-02-13 Stichting Vu-Vumc Ebv markers and systemic lupus erythematosus
CN106574223B (zh) 2014-04-02 2019-11-01 生化诊断系统公司 利用俘获缀合物的免疫测定
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
CN106645715B (zh) * 2016-11-18 2018-11-23 安徽医科大学 一种用于eb病毒衣壳抗原和核抗原1蛋白抗体联合检测的蛋白质芯片及其制备和应用
CN108490177B (zh) * 2018-02-08 2020-12-29 深圳市新产业生物医学工程股份有限公司 鼻咽癌抗体检测试剂、其制备方法及鼻咽癌检测试剂盒
CN111548411B (zh) * 2020-04-30 2022-03-29 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种中和eb病毒的单克隆抗体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116725A (en) * 1984-08-08 1992-05-26 Scripps Clinic And Research Foundation Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides
JPH04310861A (ja) * 1991-04-09 1992-11-02 Kazuo Yanagi 抗ｅｂｎａ抗体の測定方法および抗ｅｂｎａ抗体測定キット
DK1225226T3 (da) * 1992-03-13 2008-04-14 Biomerieux Bv Peptider og nucleinsyresekvenser beslægtet med Epstein-Barr-virus

Also Published As

Publication number Publication date
KR950008537A (ko) 1995-04-19
ATE231556T1 (de) 2003-02-15
DE69432043T2 (de) 2003-10-09
DE69432043D1 (de) 2003-02-27
KR100378942B1 (ko) 2003-05-22
DK0649904T3 (da) 2003-04-22
FI944225A (fi) 1995-03-15
JPH07209302A (ja) 1995-08-11
EP0649904A1 (en) 1995-04-26
CA2131874A1 (en) 1995-03-15
ZA947061B (en) 1995-04-27
AU7295694A (en) 1995-03-30
FI944225A0 (fi) 1994-09-13
JP3547493B2 (ja) 2004-07-28
EP0649904B1 (en) 2003-01-22
US5827646A (en) 1998-10-27
CA2131874C (en) 2006-03-28
FI113298B (fi) 2004-03-31
HK1001222A1 (en) 1998-06-05
AU679545B2 (en) 1997-07-03

Similar Documents

Publication Publication Date Title
ES2191673T3 (es) Reactivos de diagnostico para la deteccion de anticuerpos contra el virus de epstein barr.
ES2091765T3 (es) Procedimiento de deteccion e identificacion de constituyentes que contienen acido nucleico.
DK430384D0 (da) Fremgangsmaade til paavisning, identificering og kvantitativ bestemmelse af organismer og virus
ES554453A0 (es) Un metodo para detectar la presencia de virus lav-htlv-iii o de anticuerpo para virus lav-htlv-iii
HK1033773A1 (en) An assay for detecting anti-hepatitis c virus and the kit therefor.
ES2018648B3 (es) Metodo para la deteccion de proteinas y virus.
ATE87655T1 (de) Markierer der t-zelle aktivierung.
DK672789A (da) Nukleinsyresekvens samt rekombinant vaertscelle transformeret med samme
DE3486404D1 (de) Verfahren und produkte zur feststellung von menschlichem t-zellen-leukämie-virus.
AU637097B2 (en) Process for preparing an improved western blot immunoassay
DE59510762D1 (de) Verfahren zum besonders sensitiven Nachweis von Nukleinsäuren
AU6839090A (en) Hepatitis c assay
NZ508724A (en) Analytical method using at least two viruses to detect a target material in a sample
AU1814692A (en) Method for detecting bovine diarrhoea virus infection, nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto
ATE143142T1 (de) Immunoassay zum nachweis von antikörpern gegen hiv
MX9205203A (es) Sonda que incluye acidos nucleicos para la deteccion de virus de arn de la hepatitis c
OA09653A (en) Rubella peptides
ES2156858T3 (es) Reactivo de diagnostico para hepatitis c.
FR2728904B1 (fr) Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif
CS34889A2 (en) Method of affinitive-enzymatic compounds preparation for cholesterol's visul indication
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
ES2066547T3 (es) Peptidos, inmunoquimicamente reactivos con anticuerpos dirigidos contra virus de hepatitis no-a, no-b.
FI102381B1 (fi) Epstein-Barrin viruksen tuma-antigeeniin (EBNA) liittyviä synteettisiä polypeptidejä ja menetelmä anti-EBNA-vasta-aineiden tunnistamiseksi kudosnäytteessä
FI952778A (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
AU7377296A (en) Method for treating hepatitis virus infection